- Previous Close
724.35 - Open
715.50 - Bid --
- Ask --
- Day's Range
701.50 - 724.35 - 52 Week Range
500.45 - 1,230.00 - Volume
4,661 - Avg. Volume
7,879 - Market Cap (intraday)
10.226B - Beta (5Y Monthly) -0.31
- PE Ratio (TTM)
133.41 - EPS (TTM)
5.31 - Earnings Date May 20, 2025 - May 24, 2025
- Forward Dividend & Yield 1.25 (0.18%)
- Ex-Dividend Date Sep 13, 2024
- 1y Target Est
--
Chemfab Alkalis Limited, together with its subsidiary, Chemfab Alkalis Karaikal Limited, manufactures and sells inorganic chemicals in India and internationally. The company operates through Chemicals and Related Products/Services; and PVC-O Pipes segments. The company offers caustic soda lye and flakes, liquid chlorine, hydrogen gas, hydrochloric acid, and sodium hypochlorite/bleach liquor products; sodium chlorate; aluminum chloride; and alkali, acids, bases, solvents, alcohols, gases, ethers, aliphatics, aromatics, aldehydes ketones, amines, alkaloids, potassium chlorate, perchlorate, and other chemicals, as well as its by-products and derivatives. It also provides industrial grade and edible salt products; and PVCO pipes. The company was formerly known as Teamec Chlorates Limited and changed its name to Chemfab Alkalis Limited in July 2017. Chemfab Alkalis Limited was founded in 1985 and is based in Chennai, India.
chemfabalkalis.com210
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: CHEMFAB.NS
View MorePerformance Overview: CHEMFAB.NS
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CHEMFAB.NS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CHEMFAB.NS
View MoreValuation Measures
Market Cap
10.23B
Enterprise Value
11.00B
Trailing P/E
133.41
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
3.15
Price/Book (mrq)
2.63
Enterprise Value/Revenue
3.40
Enterprise Value/EBITDA
21.85
Financial Highlights
Profitability and Income Statement
Profit Margin
2.36%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
3.24B
Net Income Avi to Common (ttm)
76.53M
Diluted EPS (ttm)
5.31
Balance Sheet and Cash Flow
Total Cash (mrq)
27.9M
Total Debt/Equity (mrq)
20.96%
Levered Free Cash Flow (ttm)
--